🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PI3K signaling is a hallmark of many cancers. Subsets of cancers become dep...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2012-12
Trial ID
NCT02439489
Treatments Being Tested
This is an open-label, multicenter, Phase 1a study to evaluate the safety, ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2021-09-07
Trial ID
NCT04975958
Treatments Being Tested
The purpose of the study was to determine whether treatment with a PI3K inh...
Status
Completed
Location
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
Start Date
2014-03-11
Trial ID
NCT01923168
Treatments Being Tested
This pilot randomized phase I/II trial studies the side effects and best do...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2013-05
Trial ID
NCT01816984
Treatments Being Tested
This phase I clinical trial studies the side effects and the best dose of p...
Status
Completed
Location
Emory University
Start Date
2014-07-21
Trial ID
NCT02049541
Treatments Being Tested
This is an open label study of abiraterone acetate in combination with BEZ2...
Status
Completed
Location
Cedars Sinai Medical Center SC
Start Date
2012-09
Trial ID
NCT01634061
This study will assess the safety of combining two agents (everolimus and B...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2012-01
Trial ID
NCT01470209
Treatments Being Tested
This is a phase II open label fixed dose study in subjects with advanced, m...
Status
Withdrawn
Location
Huntsman Cancer Institute
Start Date
2014-05
Trial ID
NCT01550380
Treatments Being Tested
The purpose of this study is to evaluate the clinical activity of BKM120 in...
Status
Completed
Location
Dana-Farber at Faulkner Hospital
Start Date
2012-06
Trial ID
NCT01629615
Treatments Being Tested
In people whos cancers have a PIK3CA mutation, this trial will be evaluatin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01501604
Treatments Being Tested